Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sanders

Showing results (131-140 of 1,003) with videos related to

Pageof 101
Sort By:
Current Opinion in Virology|March 24, 2012
Is there a future for antiviral fusion inhibitors?Ben Berkhout, Dirk Eggink, Rogier W Sanders
Virology|December 11, 2012
Broadly neutralizing antibodies against HIV-1: templates for a vaccineMarit J van Gils, Rogier W Sanders
Trends in Microbiology|August 30, 2014
In vivo protection by broadly neutralizing HIV antibodiesMarit J van Gils, Rogier W Sanders
The Journal of Biological Chemistry|September 3, 2017
Opposites attract in bispecific antibody engineeringMarit J van Gils, Rogier W Sanders
Immunity|July 19, 2018
Hitting HIV's HarpoonMarit J van Gils, Rogier W Sanders
Current Opinion in HIV and AIDS|April 18, 2019
Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platformsPhilip J M Brouwer, Rogier W Sanders
Trends in Microbiology|June 15, 2007
Antibodies to HIV-1: aiming at the right targetDirk Eggink, Mark Melchers, Rogier W Sanders
Lancet (London, England)|April 2, 2021
Pandemic moves and countermoves: vaccines and viral variantsRogier W Sanders, Menno D de Jong
Current Pharmaceutical Design|December 7, 2010
Inhibition of HIV-1 by fusion inhibitorsDirk Eggink, Ben Berkhout, Rogier W Sanders
Current HIV Research|June 13, 2025
Germline-targeting Strategies to Induce bNAbs against HIV-1Tugba Atabey, Rogier W Sanders, Yoann Aldon
Pageof 101

Showing results (131-140 of 1,003) with videos related to

Sort By:
Pageof 101
Current Opinion in Virology|March 24, 2012
Is there a future for antiviral fusion inhibitors?Ben Berkhout, Dirk Eggink, Rogier W Sanders
Virology|December 11, 2012
Broadly neutralizing antibodies against HIV-1: templates for a vaccineMarit J van Gils, Rogier W Sanders
Trends in Microbiology|August 30, 2014
In vivo protection by broadly neutralizing HIV antibodiesMarit J van Gils, Rogier W Sanders
The Journal of Biological Chemistry|September 3, 2017
Opposites attract in bispecific antibody engineeringMarit J van Gils, Rogier W Sanders
Immunity|July 19, 2018
Hitting HIV's HarpoonMarit J van Gils, Rogier W Sanders
Current Opinion in HIV and AIDS|April 18, 2019
Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platformsPhilip J M Brouwer, Rogier W Sanders
Trends in Microbiology|June 15, 2007
Antibodies to HIV-1: aiming at the right targetDirk Eggink, Mark Melchers, Rogier W Sanders
Lancet (London, England)|April 2, 2021
Pandemic moves and countermoves: vaccines and viral variantsRogier W Sanders, Menno D de Jong
Current Pharmaceutical Design|December 7, 2010
Inhibition of HIV-1 by fusion inhibitorsDirk Eggink, Ben Berkhout, Rogier W Sanders
Current HIV Research|June 13, 2025
Germline-targeting Strategies to Induce bNAbs against HIV-1Tugba Atabey, Rogier W Sanders, Yoann Aldon
Pageof 101